↓ Skip to main content

Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran

Overview of attention for article published in Molecular Diagnosis & Therapy, November 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
86 Mendeley
Title
Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran
Published in
Molecular Diagnosis & Therapy, November 2019
DOI 10.1007/s40291-019-00434-w
Pubmed ID
Authors

Simoneide S. Titze-de-Almeida, Pedro Renato de Paula Brandão, Ingrid Faber, Ricardo Titze-de-Almeida

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 86 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 14%
Researcher 10 12%
Student > Ph. D. Student 9 10%
Student > Bachelor 7 8%
Student > Doctoral Student 4 5%
Other 10 12%
Unknown 34 40%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 12%
Pharmacology, Toxicology and Pharmaceutical Science 10 12%
Chemistry 8 9%
Agricultural and Biological Sciences 7 8%
Medicine and Dentistry 4 5%
Other 15 17%
Unknown 32 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2019.
All research outputs
#14,462,441
of 23,172,045 outputs
Outputs from Molecular Diagnosis & Therapy
#194
of 385 outputs
Outputs of similar age
#201,977
of 366,254 outputs
Outputs of similar age from Molecular Diagnosis & Therapy
#3
of 8 outputs
Altmetric has tracked 23,172,045 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 385 research outputs from this source. They receive a mean Attention Score of 3.7. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,254 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.